Share
TRUEinvivo® is pleased to announce that the patent for the DOSEmapper™ TLD bead strings and Automated DOSEmapper™ TLD Reader was granted in the USA on 26th November 2019. The patent number is 10,488,530.
Related Posts
TRUEinvivo joined SyndicateRoom investment platform in February 2019, leveraging its network to connect with potential investors, alongside Nexus Investment Ventures Ltd,
Dr. Shakar Jafari discusses Women in Innovation and cancer care on Huffington Post.
TrueInvivo’s® DOSEmapper™ showcased at BRSS, ensuring precise gamma knife dosimetry and improved radiation safety.
TRUEinvivo showcases micro silica beads at ICDA-2, University of Surrey, fostering international connections and collaborations.
